Windtree Therapeutics Inc (WINT)
4.39
+0.02
(+0.57%)
USD |
NASDAQ |
May 10, 10:02
Windtree Therapeutics Net Income (Quarterly): -5.154M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.154M |
| September 30, 2023 | -4.425M |
| June 30, 2023 | -6.601M |
| March 31, 2023 | -4.111M |
| December 31, 2022 | -9.692M |
| September 30, 2022 | -4.056M |
| June 30, 2022 | -17.33M |
| March 31, 2022 | -8.127M |
| December 31, 2021 | -13.07M |
| September 30, 2021 | -8.213M |
| June 30, 2021 | -37.39M |
| March 31, 2021 | -8.961M |
| December 31, 2020 | -7.454M |
| September 30, 2020 | -9.02M |
| June 30, 2020 | -9.558M |
| March 31, 2020 | -6.534M |
| December 31, 2019 | -7.375M |
| September 30, 2019 | -7.126M |
| June 30, 2019 | -6.437M |
| March 31, 2019 | -6.537M |
| December 31, 2018 | -9.042M |
| September 30, 2018 | -3.927M |
| June 30, 2018 | -3.052M |
| March 31, 2018 | -4.512M |
| December 31, 2017 | 2.473M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.443M |
| June 30, 2017 | -6.752M |
| March 31, 2017 | -8.724M |
| December 31, 2016 | -6.602M |
| September 30, 2016 | -8.363M |
| June 30, 2016 | -10.62M |
| March 31, 2016 | -13.90M |
| December 31, 2015 | -10.11M |
| September 30, 2015 | -21.56M |
| June 30, 2015 | -11.33M |
| March 31, 2015 | -12.18M |
| December 31, 2014 | -10.64M |
| September 30, 2014 | -11.32M |
| June 30, 2014 | -10.62M |
| March 31, 2014 | -11.48M |
| December 31, 2013 | -11.73M |
| September 30, 2013 | -12.22M |
| June 30, 2013 | -8.627M |
| March 31, 2013 | -12.64M |
| December 31, 2012 | -6.815M |
| September 30, 2012 | -13.35M |
| June 30, 2012 | -7.138M |
| March 31, 2012 | -10.02M |
| December 31, 2011 | -4.301M |
| September 30, 2011 | -4.751M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-37.39M
Minimum
Jun 2021
-4.056M
Maximum
Sep 2022
-9.507M
Average
-7.454M
Median
Dec 2020
Net Income (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | -48.40M |
| AIM ImmunoTech Inc | -12.58M |
| Perspective Therapeutics Inc | -24.68M |
| Protalix BioTherapeutics Inc | -6.044M |
| Armata Pharmaceuticals Inc | -19.85M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.959M |
| EPS Diluted (Quarterly) | -13.32 |
| Enterprise Value | -1.859M |
| Earnings Yield | -3.28K% |
| Normalized Earnings Yield | -133300.2 |